BackXBiotech Overview

XBiotech Accounts Payable

Track XBiotech's accounts payable ($860K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$857000.00
22.09% YoYΔ $-243000.00 vs prior year quarter

Peer average

Loading

XBiotech Accounts Payable History

Loading

XBiotech vs. peers: Accounts Payable Comparison

Loading

XBiotech Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

XBiotech (XBIT) FAQ

As of the most recent data (March 2026), XBIT shows a accounts payable of $860K. That compares with $1.1M in the prior-year period — down 22.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, XBIT's accounts payable is now $860K (was $1.1M) — a 22.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether XBiotech is outperforming or lagging.

Tracking XBIT's accounts payable over time shows whether XBiotech is scaling, shrinking, or reshaping that part of the business. The current reading is $860K That compares with $1.1M in the prior-year period — down 22.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has XBiotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $860K) with ownership activity and broader fundamentals.

XBiotech's accounts payable is $860K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.